Skip to content
Krystal Biotech, Inc.

Krystal Biotech, Inc. technical analysis

KRYSHealthcare Updated daily

Technical analysis of Krystal Biotech, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Krystal Biotech, Inc.

Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis bullosa and develops multiple therapeutic candidates in various clinical stages for ophthalmological, dermatological, and other disease conditions.

Description generated automatically from public sources; it may be inaccurate or out of date.

Krystal Biotech, Inc.: latest session data

Closing values for September 3, 2026, computed on the last 12 months of prices.

Close371.47 $
Change+0.61%
RSI (14)63.6
MACD7.256
ADX20.2
Volatility (ATR)3.22%
Volume vs 20-avg111%
12-month high382.54 $
12-month low242.00 $

Moving averages

21 sessions

344.15 $

+7.94%

50 sessions

349.79 $

+6.20%

200 sessions

289.56 $

+28.29%

Session levels

s2

355.43

Support

s1

362.33

Support

pivot

367.76

Pivot

r1

374.66

Resistance

r2

380.09

Resistance

How to read it

In the September 3, 2026 session Krystal Biotech, Inc. closed higher at 371.47 $, +0.61% versus the previous session.

The price sits above every moving average observed: +7.94% against the 21-session average, +6.20% against the 50 and +28.29% against the 200.

The 14-period RSI reads 63.6, in neutral territory.

MACD stands at 7.256 against a signal line at 3.843: the histogram is positive (+3.413).

ADX reads 20.2, indicating weak directionality.

Levels computed on the latest session place supports at 362.33 and 355.43 $ and resistances at 374.66 and 380.09 $, around a pivot of 367.76.

The average daily range (ATR) is 11.951 $, or 3.22% of price.

Turnover was 226.4K shares, 111% of the 20-session average.

Over the last twelve months the price ranged between 242.00 and 382.54 $, and today stands −2.89% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Krystal Biotech, Inc.

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the KRYS analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Krystal Biotech, Inc.

How is Krystal Biotech, Inc. analysed technically?

Technical analysis of Krystal Biotech, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Krystal Biotech, Inc.?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Krystal Biotech, Inc.?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Krystal Biotech, Inc. it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.